Page last updated: 2024-08-25

avarol and Carcinoma, Pancreatic Ductal

avarol has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kodama, R; Namba, T1

Other Studies

1 other study(ies) available for avarol and Carcinoma, Pancreatic Ductal

ArticleYear
Avarol induces apoptosis in pancreatic ductal adenocarcinoma cells by activating PERK-eIF2α-CHOP signaling.
    Marine drugs, 2015, Apr-16, Volume: 13, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Carcinoma, Pancreatic Ductal; Cell Line; Cell Line, Tumor; Dysidea; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Humans; Inhibitory Concentration 50; Neoplasm Proteins; Pancreatic Neoplasms; RNA Interference; Sesquiterpenes; Signal Transduction; Transcription Factor CHOP; Up-Regulation

2015